https://www.selleckchem.com/pr....oducts/trilaciclib.h
5 %), which might provide a promising way to overcome malignant tumor resistance. This work aims to design biocompatible aerogel sponges that can host and control the release of stromal cell-derived factor-1α (SDF-1α or CXCL12), a key protein for applications ranging from regenerative medicine to cancer therapy (notably for neural tissues). Miscibility of silk fibroin (SF) and hyaluronic acid (HA) was investigated by means of fluorescence and scanning electron microscopy to identify processing conditions. Series of freeze-dried spon
Curtir
Comentario
Compartilhar
